AMZN

244.45

+0.66%↑

TSLA

429.59

-3.6%↓

BKNG

4,935.39

+0.85%↑

MELI

2,108.32

-0.9%↓

NKE

60.98

-1.44%↓

AMZN

244.45

+0.66%↑

TSLA

429.59

-3.6%↓

BKNG

4,935.39

+0.85%↑

MELI

2,108.32

-0.9%↓

NKE

60.98

-1.44%↓

AMZN

244.45

+0.66%↑

TSLA

429.59

-3.6%↓

BKNG

4,935.39

+0.85%↑

MELI

2,108.32

-0.9%↓

NKE

60.98

-1.44%↓

AMZN

244.45

+0.66%↑

TSLA

429.59

-3.6%↓

BKNG

4,935.39

+0.85%↑

MELI

2,108.32

-0.9%↓

NKE

60.98

-1.44%↓

AMZN

244.45

+0.66%↑

TSLA

429.59

-3.6%↓

BKNG

4,935.39

+0.85%↑

MELI

2,108.32

-0.9%↓

NKE

60.98

-1.44%↓

Kodu・Aktsiate loetelu・Medifast Inc

Medifast Inc

Suletud

SektorTarbekaubad (tsüklilised)

11.9 1.19

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.84

Max

11.98

Põhinäitajad
By Trading Economics
Sissetulek	3.3M 2.5M
Müük	-10M 106M
P/E Sektori keskmine	36 29.124
Kasumimarginaal	2.349
Töötajad	504
EBITDA	961K 3M

Turustatistika
By TradingEconomics
Turukapital	-27M 131M
Eelmine avamishind	10.71
Eelmine sulgemishind	11.9

Uudiste sentiment

By Acuity

45%

55%

113 / 374 Pingereas Consumer cyclical

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

12.35 / 12.98 Toetus ja vastupanu

Medifast Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. nov 2025, 21:06 UTC

Suurimad hinnamuutused turgudel

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8. nov 2025, 18:10 UTC

Tulu

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8. nov 2025, 13:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. nov 2025, 12:00 UTC

Tulu

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8. nov 2025, 10:30 UTC

Tulu

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8. nov 2025, 03:50 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. nov 2025, 03:41 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. nov 2025, 03:07 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. nov 2025, 22:36 UTC

Tulu

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. nov 2025, 22:22 UTC

Tulu

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Rev $2.95B >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Net $210M >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q EPS $9.89 >CSU.T

7. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7. nov 2025, 20:59 UTC

Tulu

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7. nov 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7. nov 2025, 20:22 UTC

Tulu

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7. nov 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7. nov 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7. nov 2025, 19:31 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7. nov 2025, 19:17 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7. nov 2025, 19:09 UTC

Tulu

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7. nov 2025, 19:08 UTC

Tulu

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7. nov 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7. nov 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Medifast Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Medifast Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

12.35 / 12.98Toetus ja vastupanu

Bullish events outweigh bearish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

113 / 374 Pingereas Tarbekaubad (tsüklilised)

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Medifast Inc

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.